Ovarian Endometrioid Adenocarcinoma Recruiting Phase 1 Trials for Technetium Tc-99m pertechnetate (DB09314)

IndicationStatusPhase
DBCOND0028505 (Ovarian Endometrioid Adenocarcinoma)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03120624VSV-hIFNbeta-NIS in Treating Patients With Stage IV or Recurrent Endometrial CancerTreatment